Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Новые возможности в терапии остеоартроза
Новые возможности в терапии остеоартроза
Л.И.Алексеева, Е.П.Шарапова и др. Новые возможности в терапии остеоартроза. Справочник поликлинического врача. 2015; 6-8: 4–7.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Henrotin Y, Marty M, Mobasheri A. What is the current status of chondroitin sulfate and glucosamine for the treatment of knee osteoarthritis? Maturitas 2014; 78: 184–7.
2. Bruyère O, Scooper O, Pelletier J-P et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism 2014: p. 2-11.
3. Hochbergy MC et al. The Multicentric Osteoarthritis interVEntion Study with Sysadoa (MOVES). MOVES Steering Committee. Osteoarthritis and Cartilage 2014; 22: S7–S56.
4. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата Артра® в России. РМЖ. 2005; 13, 24 (248): 1637–40.
5. Kocsis JJ, Harkaway S, Snyder R. Biological effects of the metabolites of dimethyl sulfoxide. Ann N Y Acad Sci 1975; 243: 104–9.
6. Engelke UF, Tangerman A, Willemsen MA et al. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by onedimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed 2005; 18: 331–6.
7. Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res 2003; 23: 453–8.
8. Alam SS, Layman DL. Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann NY Acad Sci 1983; 411: 318–20.
9. Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med 1987; 110: 91–6.
10. Pagonis TA, Givissis PK, Kritis AC, Christodoulou AC. The Effect of Methylsulfonylmethane on Osteoarthritic Large Joints and Mobility. Int J Orthopaedics 2014; 1 (1): 19–24.
11. Vidyasagar S, Mukhyaprana P, Shashikiran U et al. Efficacy and tolerability of glucosamine chondroitin sulphate-methyl Sulfonyl Methane (MSM) in Osteoarthritis of Knee in Indian Patients. IJPT 2004; 3: 61–5.
2. Bruyère O, Scooper O, Pelletier J-P et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism 2014: p. 2-11.
3. Hochbergy MC et al. The Multicentric Osteoarthritis interVEntion Study with Sysadoa (MOVES). MOVES Steering Committee. Osteoarthritis and Cartilage 2014; 22: S7–S56.
4. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата Артра® в России. РМЖ. 2005; 13, 24 (248): 1637–40.
5. Kocsis JJ, Harkaway S, Snyder R. Biological effects of the metabolites of dimethyl sulfoxide. Ann N Y Acad Sci 1975; 243: 104–9.
6. Engelke UF, Tangerman A, Willemsen MA et al. Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by onedimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed 2005; 18: 331–6.
7. Ebisuzaki K. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Anticancer Res 2003; 23: 453–8.
8. Alam SS, Layman DL. Dimethyl sulfoxide inhibition of prostacyclin production in cultured aortic endothelial cells. Ann NY Acad Sci 1983; 411: 318–20.
9. Beilke MA, Collins-Lech C, Sohnle PG. Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med 1987; 110: 91–6.
10. Pagonis TA, Givissis PK, Kritis AC, Christodoulou AC. The Effect of Methylsulfonylmethane on Osteoarthritic Large Joints and Mobility. Int J Orthopaedics 2014; 1 (1): 19–24.
11. Vidyasagar S, Mukhyaprana P, Shashikiran U et al. Efficacy and tolerability of glucosamine chondroitin sulphate-methyl Sulfonyl Methane (MSM) in Osteoarthritis of Knee in Indian Patients. IJPT 2004; 3: 61–5.
Авторы
Л.И.Алексеева, Е.П.Шарапова, Н.Г.Кашеварова, С.Е.Пьяных
ФГБНУ Научно-исследовательский институт ревматологии им. В.А.Насоновой
ФГБНУ Научно-исследовательский институт ревматологии им. В.А.Насоновой
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.